SAFETY OF ALLERGEN IMMUNOTHERAPY P. 14-28
E.A. Grishchenko
Scientific and clinical advisory center of an allergology and immunology, Moscow, Russia
This article examines the rate of associated with allergen immunotherapy (AIT) adverse reactions (including severe systemic reactions), risk factors for systemic reactions, contraindications to AIT and some ways to improve the safety of this method of treatment of allergic diseases.
Key words: allergen immunotherapy, adverse reactions, contraindications to allergen immunotherapy